Previous studies reported that ECD promotes cell proliferation by regulating RB/E2F pathway-dependent cell-cycle progression and GLUT4-dependent glycolysis in breast and pancreatic cancer, respectively4,8. This evidence concerns the gene RB1 and pancreatic neoplasm.